InventHelp Inventor Develops Relaxing Massage Accessory for Pet Owners & Pets (WDH-2684)
PITTSBURGH, Dec. 6, 2021 /PRNewswire/ -- "I wanted to create a simple way to comfort my pet while reading or watching television," said an inventor, from Bethesda, Md., "so I invented the BELLY-JELLIES. My design offers a relaxing accessory for wearers and their four-legged friends."
The patent-pending invention provides a unique way to massage the feet while massaging a dog. In doing so, it enhances comfort and convenience. It also increases relaxation and it may stimulate blood flow throughout the legs. The invention features a versatile design that is easy to use so it is ideal for pet owners. Additionally, it is producible in design variations.
The original design was submitted to the Washington D.C. sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 20-WDH-2684, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at http://www.InventHelp.com.
Toitures Hogue's commitment to providing its employees with a structured, professional working environment that guarantees complete safety in the workplace, both on the job and on the job site, has just been awarded its renewed ISO 45001...
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...